表紙
市場調査レポート

カテーテルの世界市場

Global Markets for Catheters

発行 BCC Research 商品コード 229990
出版日 ページ情報 英文 177 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
カテーテルの世界市場 Global Markets for Catheters
出版日: 2016年05月09日 ページ情報: 英文 177 Pages
担当者のコメント
南北アメリカ地域、欧州・中東・ロシア・アフリカ地域、アジアの地域別レポートもございます。
概要

世界のカテーテル市場は、2016年におよそ249億米ドルの規模となり、その後、複合年間成長率(CAGR)4.7%で拡大し、2021年には313億米ドル近くに達すると予測されています。

当レポートでは、世界のカテーテル市場を取り上げ、業界の概要、人口統計との関連性、主要な材料、業界の動向、ならびに市場成長促進および阻害要因を概括し、主要地域別のカテーテル市場を分析し、各市場の予測を提示するとともに、特許状況をまとめ、主要企業のプロファイルを提供致します。

第1章 イントロダクション

第2章 サマリー

第3章 世界のカテーテル産業概要

  • 定義
  • カテーテルの開発
  • カテーテルの構造
  • カテーテルの応用
  • カテーテルの種類
  • エンドユーザーの選好

第4章 カテーテルおよび産業促進因子・抑制因子

  • 概要
  • 市場成長促進因子
  • 人口動態
  • 市場抑制因子

第5章 カテーテル材料

  • イントロダクション
  • 主な特徴
  • 組成材料
  • カテーテルコーティング剤
  • カテーテル材料の長所と短所

第6章 世界のカテーテル市場分析

  • 世界のカテーテル収益分析
  • 世界市場シェア予測:カテーテルのタイプ別
  • 心血管カテーテル
  • 泌尿器カテーテル
  • 静脈カテーテル
  • 神経血管カテーテル
  • 特殊カテーテル市場
  • 世界におけるカテーテル市場予測:地域別
  • 市場分析のまとめ

第7章 米国のカテーテル市場

  • サマリー
  • 収益分析
  • ラテンアメリカ市場

第8章 欧州のカテーテル市場

  • サマリー
  • EU諸国の死亡原因
  • 西欧の医療制度
  • 東欧の医療制度
  • 政府の規制
  • 経済状況
  • 欧州のカテーテル市場における収益分析
    • 心臓血管市場
    • 泌尿器カテーテル市場
    • 静脈カテーテル市場
    • 神経血管カテーテル市場
    • 特殊カテーテル市場

第9章 アジアにおけるカテーテル市場

  • サマリー
  • アジアのカテーテル市場における収益分析

第10章 特許分析

  • 概要
  • カテーテルのイノベーション
  • 申請者別カテーテル特許活動
  • USPTO(米国特許商標局)のカテーテル件数(年別)
  • USPTO(米国特許商標局)のカテーテル件数(種類別)
  • カテーテルの特許情報

第11章 企業ディレクトリー

  • 主要メーカー
  • M&A
  • ABBOTT LABORATORIES
  • ANGIODYNAMICS
  • ANGIOSCORE
  • ARGON MEDICAL DEVICES INC.
  • B. BRAUN MELSUNGEN AG
  • BECTON DICKINSON & CO.
  • BOSTON SCIENTIFIC
  • CARDINAL HEALTH
  • CARDIOMED SUPPLIES INC.
  • CODMAN & SHURTLEFF (DEPUY)
  • COLOPLAST GROUP
  • COOK MEDICAL
  • C. R. BARD
  • EDWARDS LIFESCIENCES
  • FLEXICATH LTD
  • GOODMAN CO. LTD
  • HOLLISTER
  • HOSPIRA INC.
  • ICU MEDICAL
  • INTEGRA LIFE SCIENCES
  • JOHNSON & JOHNSON
  • MANFRED SAUER UK LTD.
  • MAQUET/GETINGE (ATRIUM MEDICAL)
  • MEDICAL COMPONENTS INC.
  • MEDLINE INDUSTRIES
  • MEDRAD (BAYER AG)
  • MEDTRONIC
  • MERIT MEDICAL SYSTEMS INC.
  • MICROPORT SCIENTIFIC CORP.
  • PULSION MEDICAL INC.
  • ROCHESTER MEDICAL
  • SANOVAS SURGICAL TECHNOLOGIES
  • SIEMENS MEDICAL SOLUTIONS USA
  • SMITHS MEDICAL
  • SPECTRANETICS
  • ST. JUDE MEDICAL
  • STRAUB MEDICAL AG
  • STRYKER
  • TELEFLEX MEDICAL(ARROW MEDICAL PRODUCTS)
  • テルモ
  • VASCULAR SOLUTIONS
  • VOLCANO CORPORATION

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC019G

REPORT HIGHLIGHTS

The global catheter market has grown to $24.9 billion in 2016 from $23.9 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.7% from 2016 to 2021, reaching nearly $31.3 billion by 2021.

This report provides:

  • An overview of the global market for catheters.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Coverage of important segments including cardiovascular, urological, neurovascular, intravenous and specialty catheters.
  • Help determining the areas of catheter applications poised for growth and the factors driving this growth.
  • Information on new products being introduced and their future impact on the market.
  • Relevant patent analysis.
  • Profiles of leading companies in the catheter industry.

SCOPE OF REPORT

BCC Research analyzed the current catheter market based on (1) projections of worldwide, geographic and type of product market revenues through 2021, (2) on current and historical usage, (3) geographical and socio/economic market trends and (4) new applications and products.

The scope of this study encompasses the five major application segments of the catheter market. BCC Research analyzed each type of catheter segment, determined its current market status and examined its impact on future catheter sales. After this analysis, growth forecasts between 2016 and 2021 were projected. Catheter material analysis, regulatory issues and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.

Unless otherwise noted, all revenue values are in U.S. dollars at the time the research was conducted and are not adjusted for inflation.

The reviewed products in the report are not exhaustive and a number of products have been in the market for years.

ANALYST'S CREDENTIALS

Melissa Elder is an experienced healthcare market analyst, specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health and emerging healthcare technologies. Ms. Elder has more than 20 years of experience in the healthcare industry, specializing in market research for the past 16 years. This experience has given her substantial insight into pharmaceutical and medical device market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE GLOBAL MARKET FOR CATHETERS BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL MARKET FOR CATHETERS BY SEGMENT, 2014-2021 ($ MILLIONS)

CHAPTER 3 - OVERVIEW OF GLOBAL CATHETER INDUSTRY

  • DEFINITION
  • CATHETER DEVELOPMENT
  • CATHETER CONSTRUCTION
  • CATHETER APPLICATIONS
  • TYPES OF CATHETERS
    • CARDIOVASCULAR CATHETERS
      • Diagnostic Use of Cardiovascular Catheters
      • Therapeutic Use of Cardiovascular Catheters
        • TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION
        • TABLE 2 TYPES OF CARDIAC CATHETERS
      • Angiography Catheters
        • Angiographic Catheter Features
      • Electrophysiology (EP) Catheters
        • Cardiac Ablation Catheters
      • Percutaneous Coronary Intervention (PCI) Catheters
        • PCI and Stent Placement
          • TABLE 3 PCI PROCEDURES
      • Rapid Exchange Balloon Catheters
      • Over-the-Wire PCI Catheters
      • Guiding Catheters
      • Possible Complications
    • UROLOGICAL CATHETERS
      • Possible Complications from Urological Catheter Use
      • Intermittent Catheters
        • Possible Complications of Intermittent Catheters
      • Indwelling Catheterization
        • Possible Complications from Indwelling Catheters
        • Suprapubic Catheterization
        • Male External Condom Catheterization
    • INTRAVENOUS (IV) CATHETERS
      • Single-Lumen Catheters
      • Multi-Lumen Catheter
    • SPECIALTY IV CATHETERS
      • PICC
        • Advantages of PICC Lines
        • Disadvantages of PICC Lines
      • CVC
      • CVC Catheter Placement
        • Advantages to Central Venous Catheters
        • Possible Complications Due to IV Catheters
          • TABLE 4 COMPLICATIONS DUE TO IV CATHETERS
        • Dialysis Catheters
    • NEUROVASCULAR CATHETERS
    • SPECIALTY CATHETERS
      • Anesthesia Catheters
      • Thermodilution Catheters
      • Suction Catheters
      • Oximetry Catheters
      • Reproductive Catheters
      • Rectal Catheters
      • Cholangiography Catheters
  • END-USER PREFERENCES
    • CATHETER SIZE
    • MATERIAL USED
    • COATING
    • LENGTH OF TIME CATHETER IS IN THE BODY
    • INFECTION RATE
    • COST

CHAPTER 4 - CATHETERS AND INDUSTRY DRIVERS/RESTRAINTS

  • OVERVIEW
    • FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET
  • MARKET DRIVERS
    • WORLDWIDE ECONOMIC DEMOGRAPHICS
      • TABLE 5 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 2008-2014* (%)
    • WORLDWIDE POPULATION GROWTH
      • TABLE 6 LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015
      • TABLE 7 ESTIMATES OF THE TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY AT AGE 65, 2015 (%)
      • TABLE 8 BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%)
  • DEMOGRAPHIC TRENDS
    • GLOBALLY AGING POPULATION
      • TABLE 9 PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)
    • WESTERNIZATION OF DIETARY HABITS AND URBANIZATION
    • GROWING AFFLUENCE IN MIDDLE- AND LOWER-INCOME COUNTRIES
    • USE OF CATHETERS WORLDWIDE
    • CORONARY PROCEDURES
      • TABLE 10 NUMBER OF CORONARY ANGIOPLASTY PROCEDURES BY SELECTED COUNTRY, 2005-2015* (PER 100,000 POPULATIONS)
    • CANCER
      • TABLE 11 PREVALENCE OF CANCER BY SELECTED COUNTRY, 2012* (PER 100, POPULATION)
  • MARKET RESTRAINTS
    • PCI VERSUS CABG
    • COMBINED THERAPIES
    • CATHETER REUSE
    • PRODUCT DISTRIBUTION
    • REIMBURSEMENT AND REGULATION TRENDS
    • GLOBAL FINANCIAL CONDITIONS
    • THIRD PARTY COVERAGE AND REIMBURSEMENT
    • GLOBAL COST CONTAINMENT

CHAPTER 5 - CATHETER MATERIALS

  • INTRODUCTION
    • TABLE 12 CHARACTERISTICS OF CATHETER MATERIALS
  • KEY CHARACTERISTICS
    • SURFACE CHARACTERISTICS
    • CATHETERS USED IN ADVANCED IMAGING
      • MRA
      • OCT
    • RADIOPACITY IN CATHETERS
      • Determining Appropriate Properties of Radiopaque Catheters
      • Economics of Radiopacity
  • COMPONENT MATERIALS
    • LATEX
      • Latex Allergic Reactions
    • SILICONE
      • Silicone Catheter Characteristics
      • Disadvantage of Silicone Catheters
      • Cost Considerations for Silicone Catheters
    • POLYTETRAFLUOROETHYLENE (PTFE)
      • Uses
      • Cost Considerations
    • POLYURETHANE (PU)
      • Uses
      • Cost Considerations
    • POLYVINYL CHLORIDE (PVC)
      • Uses
      • Cost Considerations
    • POLYETHYLENE
      • Uses
      • Cost Considerations
  • CATHETER COATINGS
    • SILICONE ELASTOMER
    • HYDROPHILIC COATING
    • ANTIMICROBIAL COATING
      • Combating UTI
      • Combining Hydrophilic and Antimicrobial Coatings
      • Silver Coating
  • ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS
    • TABLE 13 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS

CHAPTER 6 - ANALYSIS OF THE GLOBAL CATHETER MARKET

  • GLOBAL CATHETER REVENUE ANALYSIS
    • TABLE 14 GLOBAL MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 2 GLOBAL MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
  • GLOBAL MARKET SHARE FORECAST BY TYPE OF CATHETER
    • FIGURE 3 GLOBAL MARKET SHARES OF CATHETERS BY TYPE, 2015 AND 2021 (%)
  • CARDIOVASCULAR CATHETERS
    • KEY MARKET CHALLENGES
      • Pharmacological Approaches Could Threaten Future Catheter Demand
      • Limited Clinical Data and Outcomes Statistics
    • KEY MARKET DRIVERS FOR THE CARDIOVASCULAR SEGMENT
      • Increases in the Incidence of Cardiovascular Diseases
      • Popularity of Angioplasty and Stent Placement over CABG
      • Angiography is among the Leading Diagnostic Procedures for CVD
      • Effectiveness of Interventional Cardiac Procedures Compared with Pharmaceutical-Based Therapies
    • KEY MARKET RESTRAINTS IN THE CARDIOVASCULAR MARKET
      • Constant Price Erosion
      • Decrease in Restenosis
      • Low Reimbursement Rates
      • Catheter Use in Conjunction with Stent Placement
  • CARDIOVASCULAR CATHETER REVENUE ANALYSIS
    • TABLE 15 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 4 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • Angiography
    • Balloon Catheters
    • EP Catheters
      • TABLE 16 GLOBAL MARKET FOR EP CARDIOVASCULAR CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
      • FIGURE 5 GLOBAL MARKET SHARES OF EP CARDIOVASCULAR CATHETERS BY USE, 2015 (%)
    • Guiding Catheters
    • Intravascular Ultrasound Catheters (IVUS)
  • MARKET SHARES BY COMPANY
    • FIGURE 6 GLOBAL MANUFACTURER MARKET SHARES OF ALL TYPES OF CARDIAC CATHETERS, 2015 (%)
  • UROLOGICAL CATHETERS
    • MARKET CHALLENGES
      • Infection Rates
    • MARKET DRIVERS
      • Global Aging of the Population
      • Reimbursement
      • Growth in Male External Catheters
    • UROLOGICAL CATHETER REVENUE ANALYSIS
      • TABLE 17 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
      • FIGURE 7 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
      • Intermittent Catheter Revenues
        • TABLE 18 GLOBAL MARKET FOR INTERMITTENT UROLOGICAL CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
        • FIGURE 8 GLOBAL MARKET SHARES OF INTERMITTENT UROLOGICAL CATHETERS BY USE, 2015 (%)
      • Indwelling Catheter Revenues
    • MARKET SHARES BY COMPANY
      • FIGURE 9 GLOBAL MARKET SHARES OF UROLOGICAL CATHETERS BY COMPANY, 2015 (%)
  • INTRAVENOUS CATHETERS
    • MARKET CHALLENGES
      • Healthcare-Acquired Infections and Catheters
      • Surface-Modified Catheters
      • Catheter-Related Bloodstream Infections (CRBSIs)
    • MARKET DRIVERS
      • Increasing Number of End-Stage Renal Disease Populations
      • Aging Populations
    • GLOBAL INTRAVENOUS CATHETER MARKET
      • TABLE 19 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
      • FIGURE 10 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
      • Central Venous Catheters
      • Dialysis Catheters
        • TABLE 20 GLOBAL MARKET FOR CENTRAL VENOUS CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
        • FIGURE 11 GLOBAL MARKET SHARES OF CENTRAL VENOUS CATHETERS BY USE, 2015 (%)
      • Peripheral Catheters
      • Peripherally Inserted Central Venous Catheters
    • MARKET SHARES BY COMPANY
      • FIGURE 12 GLOBAL MARKET SHARES OF IV CATHETERS BY COMPANY, 2015 (%)
  • NEUROVASCULAR CATHETERS
    • KEY MARKET CHALLENGES
      • Cost of Neurovascular Catheters
      • Availability of Pharmacological Treatment Options
      • Shortage of Qualified Professionals to Perform Surgeries
    • KEY MARKET DRIVERS
      • Enhanced Diagnostic and Imaging Technologies
      • Stenting and Aneurysm Treatments
      • New Catheter Technologies
      • Expanding Market for Unmet Treatment Options
    • NEUROVASCULAR CATHETER REVENUE ANALYSIS
      • TABLE 21 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2021 ($ MILLIONS)
      • FIGURE 13 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, 2014-2021 ($ MILLIONS)
    • MARKET SHARES BY COMPANY
      • FIGURE 14 GLOBAL MARKET SHARES OF NEUROVASCULAR CATHETERS BY COMPANY, 2015 (%)
  • SPECIALTY CATHETER MARKET
    • KEY MARKET DRIVERS
      • Demand for Enhanced Monitoring Devices
      • Effectiveness of Specialty Catheters in Surgical Applications
      • Aging Populations
      • Steady Assisted Reproductive Technology Use
    • KEY MARKET RESTRAINTS
      • Increased Cost
      • Introduction of Competing Technologies
      • Use of Thrombolytic Drugs
      • Embarrassment
  • SPECIALTY CATHETER MARKET REVENUE ANALYSIS
    • TABLE 22 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 15 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 16 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY TYPE, 2015 (%)
  • MARKET SHARES BY COMPANY
    • FIGURE 17 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY COMPANY, 2015 (%)
  • GLOBAL CATHETER MARKET BY REGION
    • TABLE 23 GLOBAL MARKET FOR CATHETERS BY REGION, THROUGH 2021 ($ MILLIONS)
    • UNITED STATES
    • EUROPE
    • ASIA
    • REST OF WORLD
      • FIGURE 18 GLOBAL MARKET SHARES OF CATHETERS BY REGION, 2015 AND 2021 (%)
  • MARKET CONCLUSIONS
    • RESTRAINTS
      • Price Erosion Due to Fierce Competition is Decreasing Revenue Potential
      • Longer Approval Times Are Delaying New Product Launches
      • Reimbursement Issues Have Affected the Use of Technologically Advanced Catheters
      • Experienced Physicians Are Often Reluctant to Accept New Device Technologies
    • DRIVERS
      • Increase in Minimally Invasive Procedures Has Led to Increased Demand for Catheters
      • Increased Demand for Disposable Catheters
      • New Technologies in Catheter Design Have Increased Catheter Use
      • Advances in Imaging Technology Have Led to New Applications Requiring the Use of Catheters

CHAPTER 7 - U.S. CATHETER MARKET

  • SUMMARY
  • REVENUE ANALYSIS OF THE U.S. CATHETER MARKET
    • TABLE 24 U.S. MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 19 U.S. MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • TABLE 25 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2007-2010 (THOUSANDS)
  • TRENDS IN PROCEDURE USAGE
  • UROLOGICAL CATHETERS OVERVIEW
  • INTRAVENOUS CATHETERS OVERVIEW
  • NEUROVASCULAR CATHETERS OVERVIEW
  • SPECIALTY CATHETERS OVERVIEW

CHAPTER 8 - EUROPEAN CATHETER MARKET

  • SUMMARY
  • CAUSES OF MORTALITY IN EU COUNTRIES
    • FIGURE 20 LEADING CAUSES OF DEATH FOR MEN AND WOMEN UNDER THE AGE OF 75 IN THE EU (%)
  • WESTERN EUROPEAN HEALTHCARE SYSTEMS
  • EASTERN EUROPEAN HEALTHCARE SYSTEMS
  • GOVERNMENT REGULATION
    • EUROPEAN UNION REGULATION
    • RUSSIAN HEALTHCARE SYSTEM REGULATION
  • ECONOMIC CONDITIONS
  • REVENUE ANALYSIS OF THE EUROPEAN MARKET FOR CATHETERS
    • TABLE 26 EUROPEAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 21 EUROPEAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • CARDIOVASCULAR MARKET OVERVIEW
    • UROLOGICAL CATHETER MARKET OVERVIEW
    • INTRAVENOUS CATHETER OVERVIEW
    • NEUROVASCULAR CATHETER OVERVIEW
    • SPECIALTY CATHETER OVERVIEW

CHAPTER 9 - ASIAN CATHETER MARKET

  • SUMMARY
    • AUSTRALIAN HEALTHCARE MARKET
      • Health Insurance in Australia
    • JAPANESE HEALTHCARE MARKET
    • INDIAN HEALTHCARE MARKET
      • Medical Insurance in India
    • CHINESE HEALTHCARE MARKET
      • Medical Device Regulations in China
      • Chinese Healthcare Institutions
      • Rural and Urban Healthcare Services
  • REVENUE ANALYSIS OF THE ASIAN MARKET FOR CATHETERS
    • TABLE 27 ASIAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 22 ASIAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • CARDIOVASCULAR MARKET OVERVIEW
    • UROLOGICAL CATHETER MARKET OVERVIEW
    • INTRAVENOUS CATHETER MARKET OVERVIEW
    • NEUROVASCULAR CATHETER MARKET OVERVIEW
    • SPECIALTY CATHETER MARKET OVERVIEW

CHAPTER 10 - PATENT ANALYSIS

  • OVERVIEW
  • CATHETER INNOVATION
    • DEVELOPMENT OF A "SMART" CATHETER
    • SANOVAS SURGICAL TECHNOLOGIES
  • CATHETER PATENT ACTIVITY BY ASSIGNEE
    • TABLE 28 USPTO CATHETER PATENT ACTIVITY BY ASSIGNEE, LAST 100 PATENTS THROUGH FEBRUARY 2016 (NO.)
  • USPTO CATHETER PATENTS BY YEAR
    • TABLE 29 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.)
    • FIGURE 23 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.)
  • USPTO CATHETER PATENTS BY TYPE
    • TABLE 30 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.)
    • FIGURE 24 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.)
  • CATHETER PATENT INFORMATION
    • TABLE 31 RECENT CATHETER PATENTS, DECEMBER 2015

CHAPTER 11 - COMPANY PROFILES

  • LEADING MANUFACTURERS
    • TABLE 32 GLOBAL CATHETER MARKET SHARES OF LEADING MANUFACTURERS, 2015 (%)
  • MERGERS/ACQUISITIONS IN THE CATHETER MARKET
    • TABLE 33 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET, 2010-2015
  • ABBOTT LABORATORIES
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 34 ABBOTT LABORATORIES CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 35 ABBOTT LABORATORIES FINANCIAL SUMMARY, 2013-2015*
  • ANGIODYNAMICS
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 36 ANGIODYNAMICS CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 37 ANGIODYNAMICS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • ARGON MEDICAL DEVICES INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 38 ARGON MEDICAL CATHETER PRODUCTS
    • RECENT ACTIVITY
  • B. BRAUN MELSUNGEN AG
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 39 B. BRAUN CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 40 B. BRAUN FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • BECTON, DICKINSON AND CO.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 41 BECTON DICKINSON CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 42 BECTON DICKINSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • RECENT ACTIVITY
  • BOSTON SCIENTIFIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 43 BOSTON SCIENTIFIC CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 44 BOSTON SCIENTIFIC FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • RECENT ACTIVITY
  • CARDINAL HEALTH
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 45 CARDINAL HEALTH (CORDIS) CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 46 CARDINAL HEALTH FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • RECENT ACTIVITY
  • CARDIOMED SUPPLIES INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 47 CARDIOMED CATHETER PRODUCTS
  • CODMAN NEURO (DEPUY)
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 48 CODMAN CATHETER PRODUCTS
  • COLOPLAST A/S
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 49 COLOPLAST CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 50 COLOPLAST FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • COOK MEDICAL INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 51 COOK MEDICAL CATHETER PRODUCTS
  • C. R. BARD
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 52 C. R. BARD CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 53 C. R. BARD FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • EDWARDS LIFESCIENCES CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 55 EDWARDS LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • FLEXICATH LTD
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 56 FLEXICATH CATHETER PRODUCTS
  • GOODMAN CO. LTD.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 57 GOODMAN CATHETER PRODUCTS
  • HOLLISTER INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 58 HOLLISTER CATHETER PRODUCTS
  • ICU MEDICAL INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 59 ICU MEDICAL CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 60 ICU MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
  • INTEGRA LIFESCIENCES
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 61 INTEGRA LIFESCIENCES CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 62 INTEGRA LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • JOHNSON & JOHNSON
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 63 JOHNSON & JOHNSON CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 64 JOHNSON & JOHNSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • RECENT ACTIVITY
  • MANFRED SAUER GMBH
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 65 MANFRED SAUER CATHETER PRODUCTS
  • MAQUET GETINGE GROUP
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 66 MAQUET GETINGE CATHETER PRODUCTS
  • MEDICAL COMPONENTS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 67 MEDICAL COMPONENTS CATHETER PRODUCTS
  • MEDLINE INDUSTRIES INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 68 MEDLINE CATHETER PRODUCTS
  • MEDTRONIC
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 69 MEDTRONIC CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 70 MEDTRONIC FINANCIAL SUMMARY 2013-2015* ($ MILLIONS)
    • RECENT ACTIVITY
  • MERIT MEDICAL SYSTEMS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 71 MERIT MEDICAL SYSTEMS CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 72 MERIT MEDICAL SYSTEMS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • MICROPORT SCIENTIFIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 73 MICROPORT SCIENTIFIC CATHETER PRODUCTS
  • PULSION MEDICAL SYSTEMS SE
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 74 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS
  • SANOVAS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 75 SANOVAS CATHETER PRODUCTS
  • SIEMENS MEDICAL SOLUTIONS USA INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 76 SIEMENS CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 77 SIEMENS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • SMITHS GROUP PLC
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 78 SMITHS MEDICAL CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 79 SMITHS GROUP FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • SPECTRANETICS
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 80 SPECTRANETICS CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 81 SPECTRANETICS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
    • BUSINESS ACTIVITIES
  • ST. JUDE MEDICAL
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 82 ST. JUDE MEDICAL CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 83 ST. JUDE MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • STRAUB MEDICAL AG
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 84 STRAUB MEDICAL AG CATHETER PRODUCTS
  • STRYKER
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 85 STRYKER CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 86 STRYKER FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • TELEFLEX INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 87 TELEFLEX CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 88 TELEFLEX FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • TERUMO CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 89 TERUMO CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 90 TERUMO FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
  • VASCULAR SOLUTIONS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 91 VASCULAR SOLUTIONS CATHETER PRODUCTS
    • FINANCIAL SUMMARY
      • TABLE 92 VASCULAR SOLUTIONS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
  • VOLCANO CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
      • TABLE 93 VOLCANO CORP. CATHETER PRODUCTS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR CATHETERS BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: INDICATIONS FOR CARDIAC CATHETERIZATION
    • TABLE 2: TYPES OF CARDIAC CATHETERS
    • TABLE 3: PCI PROCEDURES
    • TABLE 4: COMPLICATIONS DUE TO IV CATHETERS
    • TABLE 5: HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 2008-2014* (%)
    • TABLE 6: LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015
    • TABLE 7: ESTIMATES OF THE TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY AT AGE 65, 2015 (%)
    • TABLE 8: BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%)
    • TABLE 9: PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)
    • TABLE 10: NUMBER OF CORONARY ANGIOPLASTY PROCEDURES BY SELECTED COUNTRY, 2005-2015* (PER 100,000 POPULATIONS)
    • TABLE 11: PREVALENCE OF CANCER BY SELECTED COUNTRY, 2012* (PER 100,000 POPULATION)
    • TABLE 12: CHARACTERISTICS OF CATHETER MATERIALS
    • TABLE 13: ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS
    • TABLE 14: GLOBAL MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR EP CARDIOVASCULAR CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 18: GLOBAL MARKET FOR INTERMITTENT UROLOGICAL CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
    • TABLE 19: GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET FOR CENTRAL VENOUS CATHETERS BY USE, THROUGH 2021 ($ MILLIONS)
    • TABLE 21: GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2021 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR CATHETERS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 24: U.S. MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 25: U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2007-2010 (THOUSANDS)
    • TABLE 26: EUROPEAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 27: ASIAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 28: USPTO CATHETER PATENT ACTIVITY BY ASSIGNEE, LAST 100 PATENTS THROUGH FEBRUARY 2016 (NO.)
    • TABLE 29: USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.)
    • TABLE 30: USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.)
    • TABLE 31: RECENT CATHETER PATENTS, DECEMBER 2015
    • TABLE 32: GLOBAL CATHETER MARKET SHARES OF LEADING MANUFACTURERS, 2015 (%)
    • TABLE 33: MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET, 2010-2015
    • TABLE 34: ABBOTT LABORATORIES CATHETER PRODUCTS
    • TABLE 35: ABBOTT LABORATORIES FINANCIAL SUMMARY, 2013-2015*
    • TABLE 36: ANGIODYNAMICS CATHETER PRODUCTS
    • TABLE 37: ANGIODYNAMICS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 38: ARGON MEDICAL CATHETER PRODUCTS
    • TABLE 39: B. BRAUN CATHETER PRODUCTS
    • TABLE 40: B. BRAUN FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 41: BECTON DICKINSON CATHETER PRODUCTS
    • TABLE 42: BECTON DICKINSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 43: BOSTON SCIENTIFIC CATHETER PRODUCTS
    • TABLE 44: BOSTON SCIENTIFIC FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 45: CARDINAL HEALTH (CORDIS) CATHETER PRODUCTS
    • TABLE 46: CARDINAL HEALTH FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 47: CARDIOMED CATHETER PRODUCTS
    • TABLE 48: CODMAN CATHETER PRODUCTS
    • TABLE 49: COLOPLAST CATHETER PRODUCTS
    • TABLE 50: COLOPLAST FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 51: COOK MEDICAL CATHETER PRODUCTS
    • TABLE 52: C. R. BARD CATHETER PRODUCTS
    • TABLE 53: C. R. BARD FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 54: EDWARDS LIFESCIENCES CATHETER PRODUCTS
    • TABLE 55: EDWARDS LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 56: FLEXICATH CATHETER PRODUCTS
    • TABLE 57: GOODMAN CATHETER PRODUCTS
    • TABLE 58: HOLLISTER CATHETER PRODUCTS
    • TABLE 59: ICU MEDICAL CATHETER PRODUCTS
    • TABLE 60: ICU MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
    • TABLE 61: INTEGRA LIFESCIENCES CATHETER PRODUCTS
    • TABLE 62: INTEGRA LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 63: JOHNSON & JOHNSON CATHETER PRODUCTS
    • TABLE 64: JOHNSON & JOHNSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 65: MANFRED SAUER CATHETER PRODUCTS
    • TABLE 66: MAQUET GETINGE CATHETER PRODUCTS
    • TABLE 67: MEDICAL COMPONENTS CATHETER PRODUCTS
    • TABLE 68: MEDLINE CATHETER PRODUCTS
    • TABLE 69: MEDTRONIC CATHETER PRODUCTS
    • TABLE 70: MEDTRONIC FINANCIAL SUMMARY 2013-2015* ($ MILLIONS)
    • TABLE 71: MERIT MEDICAL SYSTEMS CATHETER PRODUCTS
    • TABLE 72: MERIT MEDICAL SYSTEMS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 73: MICROPORT SCIENTIFIC CATHETER PRODUCTS
    • TABLE 74: PULSION MEDICAL SYSTEMS CATHETER PRODUCTS
    • TABLE 75: SANOVAS CATHETER PRODUCTS
    • TABLE 76: SIEMENS CATHETER PRODUCTS
    • TABLE 77: SIEMENS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 78: SMITHS MEDICAL CATHETER PRODUCTS
    • TABLE 79: SMITHS GROUP FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 80: SPECTRANETICS CATHETER PRODUCTS
    • TABLE 81: SPECTRANETICS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
    • TABLE 82: ST. JUDE MEDICAL CATHETER PRODUCTS
    • TABLE 83: ST. JUDE MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 84: STRAUB MEDICAL AG CATHETER PRODUCTS
    • TABLE 85: STRYKER CATHETER PRODUCTS
    • TABLE 86: STRYKER FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 87: TELEFLEX CATHETER PRODUCTS
    • TABLE 88: TELEFLEX FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 89: TERUMO CATHETER PRODUCTS
    • TABLE 90: TERUMO FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS)
    • TABLE 91: VASCULAR SOLUTIONS CATHETER PRODUCTS
    • TABLE 92: VASCULAR SOLUTIONS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS)
    • TABLE 93: VOLCANO CORP. CATHETER PRODUCTS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR CATHETERS BY SEGMENT, 2014-2021 ($ MILLIONS)
    • FIGURE 1: FACTORS INFLUENCING THE MEDICAL DEVICE MARKET
    • FIGURE 2: GLOBAL MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 3: GLOBAL MARKET SHARES OF CATHETERS BY TYPE, 2015 AND 2021 (%)
    • FIGURE 4: GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 5: GLOBAL MARKET SHARES OF EP CARDIOVASCULAR CATHETERS BY USE, 2015 (%)
    • FIGURE 6: GLOBAL MANUFACTURER MARKET SHARES OF ALL TYPES OF CARDIAC CATHETERS, 2015 (%)
    • FIGURE 7: GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 8: GLOBAL MARKET SHARES OF INTERMITTENT UROLOGICAL CATHETERS BY USE, 2015 (%)
    • FIGURE 9: GLOBAL MARKET SHARES OF UROLOGICAL CATHETERS BY COMPANY, 2015 (%)
    • FIGURE 10: GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 11: GLOBAL MARKET SHARES OF CENTRAL VENOUS CATHETERS BY USE, 2015 (%)
    • FIGURE 12: GLOBAL MARKET SHARES OF IV CATHETERS BY COMPANY, 2015 (%)
    • FIGURE 13: GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, 2014-2021 ($ MILLIONS)
    • FIGURE 14: GLOBAL MARKET SHARES OF NEUROVASCULAR CATHETERS BY COMPANY, 2015 (%)
    • FIGURE 15: GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 16: GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY TYPE, 2015 (%)
    • FIGURE 17: GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY COMPANY, 2015 (%)
    • FIGURE 18: GLOBAL MARKET SHARES OF CATHETERS BY REGION, 2015 AND 2021 (%)
    • FIGURE 19: U.S. MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 20: LEADING CAUSES OF DEATH FOR MEN AND WOMEN UNDER THE AGE OF 75 IN THE EU (%)
    • FIGURE 21: EUROPEAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 22: ASIAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 23: USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.)
    • FIGURE 24: USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.)
Back to Top